SL
OVID icon

Siren LLC’s Ovid Therapeutics OVID Stock Holding History

Siren LLC’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,850,000
Closed -$2.66M – 134
2024
Q4 		$2.66M Hold
2,850,000
– – 0.12% 84
2024
Q3 		$3.36M Buy
+2,850,000
New +$2.98M 0.17% 76

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Siren LLC's OVID Position: Q1 2025 in Review

Siren LLC sold out of Ovid Therapeutics (OVID) in Q1 2025, closing a stake of 2,850,000 shares — an estimated $2.66M sold.

Siren LLC first reported a position in OVID in Q3 2024 and held it in 2 quarters. The position peaked at $3.36M in Q3 2024. 82 funds tracked by Wall St. Rank hold OVID as of Q1 2025.

  • Siren LLC reported no remaining Ovid Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Siren LLC sold 2,850,000 Ovid Therapeutics shares in Q1 2025, an estimated $2.66M.
  • Siren LLC first reported a position in Ovid Therapeutics in Q3 2024 and held it in 2 quarters.
  • Siren LLC's Ovid Therapeutics position peaked at $3.36M in Q3 2024.
  • 82 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2025.

Based on Siren LLC's 13F filing for Q1 2025, filed 14 May 2025.